JK
Therapeutic Areas
Apertor Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| mTORC1 / 4EBP1 Interceptor | Non Small Cell Lung Cancer | IND-Enabling |
| RAS Pathway Interceptor | Non Small Cell Lung, Pancreatic, Colorectal Cancer | Discovery |
| Undisclosed Target Program | Oncology | Discovery |